17 July 2025 in Journal of Clinical Investigation
Pathogenic variants in the gene TMPRSS3 are a common cause of hearing loss in humans, although the causal mechanisms remain unknown. Previous work has shown that
Tmprss3
Y260X/Y260X
mice exhibit normal hair cell development, mechanosensory transduction, and spiral ganglion patterning, but experience rapid hair cell death from P12 to P14 at the onset of hearing. Here, we demonstrate that
Tmprss3
Y260X/Y260X
mice display an early and temporary spike in endocochlear potential (EP) prior to the onset of hair cell death. In vitro experiments with cochlear explants from
Tmprss3
Y260X/Y260X
mice and in vivo studies with
Tmprss3
Y260X/Y260X
mice crossed with 2 different mutant models that lacked EP generation promoted hair cell survival. Furthermore, systemic administration of furosemide, a drug that reduces EP in vivo, reduced hair cell death in
Tmprss3
Y260X/Y260X
mice. These findings suggest that extracellular factors, including EP, play a role in TMPRSS3-related hair cell survival and hearing loss, and suggest that modulating EP could be a therapeutic strategy.
1 September 2026 in Otology & Neurotology
Objective: Identify common characteristics in patients who had hearing improvement after cerebellopontine angle (CPA) meningioma resection. Patients: Adult patients who underwent hearing-preservation-intent CPA meningioma resection. Intervention(s): Data collected included patient, tumor, and surgical factors. Surgical approaches were retrosigmoid, combined petrosal, or anterior petrosectomy. Main outcome measure(s): Preoperative and postoperative word recognition scores (WRS), pure-tone average (PTA), and AAO-HNS hearing classification. Results: Fifteen female patients (mean age: 52.5±14.4 y) underwent resection of CPA meningiomas (mean CPA dimension: 3.2±1.6 cm). Facial nerve function (House-Brackmann grade I or II) was preserved in all cases. Six of 10 (60%) of patients with serviceable preop hearing had hearing preserved, and 3 patients (20%) demonstrated improvement in AAO-HNS hearing class. These patients had preoperative WRS ranging from 0% to 32% and PTA from 32.5 to 42.5 dB. Tumors were inframeatal, retromeatal, or intracanalicular, with gross total resection in 2 cases. Median AAO-HNS hearing class improved from D to B, and mean WRS increased from 21.3% to 80.3% ( P =0.01). Patients with hearing improvement had a worse mean preoperative WRS than patients without improvement (21.3% vs. 80%, P <0.01). No other single variable—including tumor CPA and IAC dimensions, location, surgical approach, extent of resection, age, or PTA—was predictive of hearing improvement. Conclusions: Hearing improvement was observed in a subset of CPA meningioma patients, particularly those with disproportionately poor WRS relative to PTA. These patients may benefit from a hearing-preservation surgical strategy.